Investigating how a hormone affects heart health during stress
Role of arginine-vasopressin and V1A receptor in psychosocial stress-induced myocardial injury
This study is looking at how a hormone called arginine-vasopressin might help protect your heart during stressful times, especially if you experience anxiety or feel socially isolated, and it could lead to better understanding for both animals and people.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Rio Grande Valley NIH-funded |
| Lab location | 1 site (Edinburg, United States) |
| Project ID | NIH-10902002 on NIH RePORTER |
What this research studies
This research explores the role of arginine-vasopressin (AVP) and its receptor in the heart's response to psychosocial stress. It aims to understand how stress-related factors like anxiety and social isolation can lead to heart problems such as myocardial infarction. By studying the interactions between the brain and heart, the researchers hope to identify how AVP can help protect heart function during stressful situations. The study involves both animal models and potential implications for human health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing high levels of psychosocial stress, particularly those with a history of heart issues.
Not a fit: Patients without any psychosocial stress or those who do not have cardiovascular risk factors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that protect the heart from stress-induced damage.
How similar studies have performed: Previous research has shown promising results in understanding the role of stress hormones in heart health, suggesting that this approach could yield valuable insights.
Where this research is happening
Edinburg, United States
- University of Texas Rio Grande Valley — Edinburg, United States (Active)
Researchers
- Principal investigator: Gil, Mario — University of Texas Rio Grande Valley
- Study coordinator: Gil, Mario
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.